REG - AIM - AIM Notice - 02/12/2022

NetcallAnnouncement

02/12/2022 09:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221202:nRSB3163Ia&default-theme=true

RNS Number : 3163I  AIM  02 December 2022

NOTICE

 

02/12/2022 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 ADVANCED ONCOTHERAPY PLC
 250,000  ORDINARY SHARES OF 25P EACH, FULLY PAID  (BD6SX10)(GB00BD6SX109)

 

 ATTRAQT GROUP PLC
 9,074,685  ORDINARY SHARES OF 1P EACH FULLY PAID  (BMJJFZ1)(GB00BMJJFZ18)

 

 CRESTCHIC PLC
 21,600  ORDINARY SHARES OF 10P EACH, FULLY PAID  (B0SPFW3)(GB00B0SPFW38)

 

 EAGLE EYE SOLUTIONS GROUP PLC
 46,574  ORDINARY SHARES OF 1P EACH FULLY PAID  (BKF1YD8)(GB00BKF1YD83)

 

 HARLAND & WOLFF GROUP HOLDINGS PLC
 877,193  ORDINARY SHARES OF 1P EACH, FULLY PAID  (BLPJ127)(GB00BLPJ1272)

 

 INTELLIGENT ULTRASOUND GROUP PLC
 29,187,468  ORDINARY SHARES OF 1P EACH FULLY PAID  (BN791Q3)(GB00BN791Q39)

 

 LEARNING TECHNOLOGIES GROUP PLC
 16,500  ORDINARY SHARES OF 0.375P EACH FULLY PAID  (B4T7HX1)(GB00B4T7HX10)

 

 NETCALL PLC
 107,680  ORDINARY SHARES OF 5P EACH, FULLY PAID  (0006053)(GB0000060532)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBSBDDRUGDGDB